2015
DOI: 10.1097/jcp.0000000000000305
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy and Safety of Sertindole in Schizophrenia

Abstract: Sertindole is an atypical antipsychotic reintroduced into the European market in 2005 after a reevaluation of its risks and benefits, under the agreement that close electrocardiographic screening would be conducted. It has a high affinity for dopamine D2, serotonin 5-HT2A and 5-HT2C, and α1 adrenergic receptors. Moreover, sertindole shows modest affinity for H1-histaminergic and muscarinic receptors. The pharmacological properties, clinical efficacy, safety, and tolerability of sertindole are covered in this a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
15
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 81 publications
(93 reference statements)
0
15
0
Order By: Relevance
“…Sertindole is an indole derivative with a high affinity for dopamine D 2 , serotonin 5-HT 2A and 5-HT 2C , and α 1 adrenergic receptors [ 120 ]. It has also some affinity for histamine H 1 and muscarinic receptors.…”
Section: Classical Approaches To Treat Schizophreniamentioning
confidence: 99%
“…Sertindole is an indole derivative with a high affinity for dopamine D 2 , serotonin 5-HT 2A and 5-HT 2C , and α 1 adrenergic receptors [ 120 ]. It has also some affinity for histamine H 1 and muscarinic receptors.…”
Section: Classical Approaches To Treat Schizophreniamentioning
confidence: 99%
“…This drug was authorized and introduced into the market in 1996 but was voluntarily withdrawn in 1998 after numerous cardiac adverse effects were reported . Various studies revealed that increased drug concentration could lead to increased risk of QTc prolongation. , However, after a reevaluation of its risks and benefits, sertindole was reintroduced into the European market in 2005, and the drug is currently available in several countries …”
Section: Fluorine-containing Pharmaceuticals Withdrawn From the Marketmentioning
confidence: 99%
“…313,314 However, after a reevaluation of its risks and benefits, sertindole was reintroduced into the European market in 2005, and the drug is currently available in several countries. 315 6.1.2. Aromatic Trifluoromethyl-Substituted Compounds.…”
Section: Fluorine-containing Pharmaceuticals Withdrawn From the Marketmentioning
confidence: 99%
“…Indole ring is present in a great variety of biologically relevant compounds, from the amino acid tryptophan to the hormone melatonin and the neurotransmitter serotonin as well as complex plant secondary metabolites such as vincristine and reserpine, used as chemotherapeutic agents [1] and in hypertension management. [2] Furthermore, the indole ring has attracted considerable attention as scaffold for the development of a great variety of drugs, such as sumatriptan, [3] tadalafil, [4] sertindole, [5] bazedoxifene, [6] just to cite a few, and many others are still under investigation. [7] A large variety of indole synthesis have been established (a selection is reported in Scheme 1).…”
Section: Introductionmentioning
confidence: 99%